Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Tremor
Interventions
DRUG

Dexmedetomidine

An intravenous bolus of dexmedetomidine 30 mcg (7,5 mL) administered at least five minutes after birth, in participants with shivering grade 3 or 4 on a scale described by Crossley and Mahajan.

DRUG

Normal saline

An intravenous bolus of normal saline (7,5 mL) administered at least five minutes after birth, in participants with shivering grade 3 or 4 on a scale described by Crossley and Mahajan.

Trial Locations (1)

H3T 1C4

St-Justine's Hospital, Montreal

All Listed Sponsors
lead

St. Justine's Hospital

OTHER

NCT02384343 - Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia | Biotech Hunter | Biotech Hunter